Skip to main content

Table 5 Univariate analysis of risk factors for lateral lymph node metastasis

From: Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients

 

OR

95%CI

P value

 

Lower

Upper

 

Gender

(male vs. female)

1.60

1.00

2.56

0.051

Age (years)

    

0.025a

≤35

2.37

1.35

4.17

0.003

35–45

1.56

0.88

2.78

0.132

45–55

1.45

0.82

2.57

0.206

> 55

1

   

Tumor size(cm)

    

< 0.001a

≤0.5

1

   

0.5–1.0

1.46

0.66

3.23

0.346

1.0–2.0

2.47

1.13

5.40

0.024

> 2.0

4.30

1.89

9.81

0.001

Ultrasound feature

 Microcalcification

(yes vs. no)

1.30

0.87

1.95

0.205

 Hypoechoic solid nodules

(yes vs. no)

0.80

0.48

1.33

0.392

 Irregular shape

(yes vs. no)

1.09

0.74

1.61

0.671

 Infiltrative margins

(yes vs. no)

1.04

0.66

1.64

0.865

 Intra-nodular vascularity

(yes vs. no)

1.01

0.66

1.56

0.953

Multifocality

(yes vs. no)

1.32

0.88

1.97

0.175

Bilateral

(yes vs. no)

1.38

0.88

2.15

0.160

Extrathyroidal extension

(yes vs. no)

1.60

1.06

2.43

0.026

Distant metastasis

(yes vs. no)

0.99

1.38

7.10

0.992

Hashimoto’s thyroiditis

(yes vs. no)

1.22

0.83

1.81

0.311

The number of CLNM

    

< 0.001a

0

1

   

1–3

3.31

2.13

5.15

< 0.001

> 3

12.24

5.98

25.06

< 0.001

TSH value

 

0.98

0.86

1.11

0.711

  1. ameans the global p-values; CLNM central lymph node metastasis
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us